Recent studies suggest that anticardiolipin antibodies may be responsible for a variety of laboratory and clinical phenomena in up to 61% of patients with systemic lupus erythematosus (SLE). These include lupus anticoagulant, biological false positive test for syphilis, thrombocytopenia, recurrent abortions, intrauterine fetal death, and thromboembolism. [1] [2] [3] [4] [5] We describe here a young woman with SLE, not receiving corticosteroid treatment, who developed a cerebrovascular accident and acute myocardial infarction in the presence of a high titre of anticardiolipin antibodies. 
